Femasys Inc (FEMY) USD0.001
Sell:$0.81Buy:$0.83
$0.03
(3.61%)
- This stock can be held in a
Stocks and Shares ISA$0.03
(3.61%)$0.03
(3.61%)Company Information
About this company
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.
Key people
Key facts
- EPICFEMY
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- ISINUS31447E1055
- Market cap$22.61m
- Employees69
- Shares in issue32.49m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.